Blog
AppLovin E-Commerce Ads, Self-Serve and GenAI Are Catalysts
AppLovin APP has spent years building an AI-driven ad stack around its Axon engine and a unified marketplace that matches advertiser demand with publisher supply. Now management is pushing that same
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Eli Lilly LLY announced positive top-line results from a late-stage study evaluating its experimental once-weekly weight-loss drug, retatrutide, in adults with type II diabetes (T2D)
This study
Top 2 Profitable Stocks to Buy Right Now (NVDA, MU)
Investors should prioritize companies that deliver strong returns after accounting for all operating and non-operating expenses. Consequently, businesses with consistent profits tend to be more
Is APP Overvalued? Valuation, Buybacks and 2026 Margin Signals
AppLovin APP is being valued like a premium, cash-rich growth platform. That premium can work for investors when execution stays clean and profitability stays durable.
The real question is not
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
Novartis NVS is doubling down on precision oncology with a targeted bolt-on acquisition that strengthens its position in one of the largest segments of breast cancer.
Novartis has agreed to acquire
AppLovin's Axon and MAX Power 70% Revenue Growth in 2025
AppLovin Corporation APP has repositioned itself as an end-to-end, AI-powered advertising platform built to help businesses reach audiences and monetize supply across mobile and connected TV. In
Equinor Expands Barents Sea Potential With New Oil Discovery
Equinor ASA EQNR, a Norwegian integrated energy company, announced a new oil discovery in the Barents Sea, which will be tied to the Johan Castberg field. The Johan Castberg field is located in the
MarketAxess Stock Remains a Hold for Now: What's Limiting the Upside?
MarketAxess Holdings Inc. MKTX, a leading electronic marketplace, maintains a strong position in global fixed-income trading and continues to evolve by shifting toward faster-growing
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with active psoriatic arthritis (PsA). The decision adds a second major
Theravance's Q4 Earnings and Revenues Miss Estimates
Theravance Biopharma TBPH reported fourth-quarter 2025 adjusted earnings of 6 cents per share, which missed the Zacks Consensus Estimate of 44 cents. In the year-ago quarter, the company had
DANA Stock Up 34% YTD: Should You Buy, Hold or Sell the Stock Now?
Dana Inc. DAN is a global leader in providing power-conveyance and energy-management solutions for on-highway vehicles. The company’s portfolio enhances the efficiency, performance and
Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?
Archer Daniels Midland Company ADM is focused on optimizing the organizational and operational structure. The company is actively managing productivity and innovation as well as aligning work to the
Will Snap-on's Operational Agility, RCI Plan & Innovations Aid Growth?
Snap-on Incorporated SNA is making solid progress on its strategic priorities. SNA’s strengths are rooted in its powerful brand, differentiated business model and strong customer relationships. The
Short-Term Fear, Long-Term Opportunity
The drums of war are beating and the stress of the oil market is weighing heavily on the U.S. equity market. Before war broke out in the Middle East, the U.S. market had already been hit with its
Skip Pure-Play Risks: NVIDIA Leads Safer Quantum Investing in 2026
Quantum computing is one of the most exciting frontiers in technology today. But for investors, it is still highly uncertain. Pure-play quantum stocks have gained attention, but they come with
NERA Incurs a Loss in Q4 Due to Escalating Costs, Stock Down 5%
Shares of New England Realty Associates Limited Partnership NEN have declined 4.6% since the company reported its earnings for the quarter ended Dec. 31, 2025. This compares to the S&P 500 index’s
Value Line's Q3 Earnings Rise Y/Y Driven by Investment Gains
Shares of Value Line, Inc. VALU have declined 3.4% since the company reported its earnings for the quarter ended Jan. 31, 2026, underperforming the S&P 500 index’s modest 0.1% decline over the same
NU's Efficiency Edge: A Key Factor Driving Its Premium Narrative
Nu Holdings NU remains a credit-heavy lender on the surface, but one factor clearly separates it from traditional financial institutions: its efficiency ratio. This single metric is increasingly
Realty Income & Apollo Set to Form a Strategic Partnership
Realty Income Corporation O announced that Apollo-managed funds and affiliates plan to invest $1 billion in Realty Income. This investment will secure a 49% interest in a new joint venture (JV)
UiPath's Debt-Free Balance Sheet Fuels Strategic Flexibility
UiPath PATH stands out in the competitive automation landscape for one simple reason: financial autonomy. At the close of the fourth quarter of fiscal 2026, the company held $1.47 billion in cash
Prologis & GIC Establishes $1.6B U.S. Build-to-Suit Logistics Joint Venture
Prologis, Inc. PLD and GIC, a leading global institutional investor, announced the formation of a joint venture (JV) to focus on developing and owning build-to-suit logistics facilities in key U.S
SailPoint Q4 Earnings Match Estimates, Revenues Up Y/Y, Shares Fall
SailPoint SAIL reported fourth-quarter fiscal 2026 earnings of 8 cents per share, in line with the Zacks Consensus Estimate. The company reported a loss of $4.29 in the year-ago quarter.Revenues
Make the Most of High Oil Prices With FTI, WFRD & NBR Shares
Oil has already taken the top spot in the stock market, as the world watches high commodity prices and their deterring effect on economies. In the meantime, investors willing to capitalize on the
Contributions From Rising Customer Base, Strategic Investments Aid SWX
Southwest Gas SWX benefits from contributions from an expanding customer base, driven by regional economic development and new rates. Debt management and systematic capital investment to strengthen
3 Reasons Why Growth Investors Shouldn't Overlook Alvopetro Energy (ALVOF)
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth


